ArticleThe Journal of infectious diseases2009
Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.
Article in The Journal of infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 38 citations in OpenAlex.
- Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results.Nature medicine · 2023Trial
- Efficacy of single-dose HPV vaccination among young African women.NEJM evidence · 2022Trial
- Trial
- Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children.The Journal of infectious diseases · 2012Trial
- Complementary measurement of nontyphoidalHeliyon · 2023Article
- Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine.Frontiers in immunology · 2020Article
- Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges.Vaccine · 2018Article
- Prophylactic immunization with human papillomavirus vaccines induces oral immunity in mice.The Laryngoscope · 2018Article
- Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial.The Journal of infectious diseases · 2016Article
- The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer.Cancer · 2016Review
- Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids.British journal of cancer · 2016Article
- Analysis of liquid bead microarray antibody assay data for epidemiologic studies of pathogen-cancer associations.Journal of immunological methods · 2015Article
- Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.The Journal of infectious diseases · 2013Article
- Emerging human papillomavirus vaccines.Expert opinion on emerging drugs · 2012Review
- Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.The Journal of infectious diseases · 2012Article
- Oral Immunoglobulin Levels are Not a Good Surrogate for Cervical Immunoglobulin Levels.Frontiers in oncology · 2012Article
- Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.The Journal of infectious diseases · 2011Article
- Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers.British journal of cancer · 2011Article
- Bacterial and viral pathogens in saliva: disease relationship and infectious risk.Periodontology 2000 · 2011Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
Abstract
We sought to determine whether oral fluid can be used to assess serum human papillomavirus (HPV) antibody status by enrolling women who had received a prophylactic HPV-16 vaccine in a new follow-up study. After the prophylactic HPV-6/11/16/18 vaccine was licensed in the United States, we administered it to consenting participants. With serologic findings used as the reference standard, The sensitivity of oral fluid was 49.6% (95% confidence interval [CI], 42.0%-57.3%) before and 100% (95% CI, 92.0%-100%) after administration of the quadrivalent vaccine. Oral fluid may have the potential to be used for monitoring of prophylactic HPV vaccines in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.